SPDR S&P Biotech ETF $XBI Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 41.4% during the 1st quarter, HoldingsChannel.com reports. The firm owned 391,243 shares of the exchange traded fund’s stock after purchasing an additional 114,638 shares during the period. SG Americas Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $49,973,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Banque Pictet & Cie SA boosted its holdings in shares of SPDR S&P Biotech ETF by 24.1% in the 4th quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after buying an additional 12,595 shares during the period. Apella Capital LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $490,000. Keystone Investors PTE Ltd. acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $12,022,000. Mirae Asset Global Investments Co. Ltd. raised its stake in SPDR S&P Biotech ETF by 106.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after acquiring an additional 13,729 shares during the period. Finally, Greystone Financial Group LLC bought a new position in SPDR S&P Biotech ETF in the fourth quarter worth about $658,000.

SPDR S&P Biotech ETF Stock Up 3.7%

Shares of NYSEARCA XBI opened at $145.86 on Tuesday. The firm’s 50-day moving average price is $133.84 and its two-hundred day moving average price is $127.95. SPDR S&P Biotech ETF has a 52-week low of $80.90 and a 52-week high of $146.77. The stock has a market capitalization of $9.31 billion, a P/E ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.